Plasma clusterin a possible biomarker of AD severity


REPORT FROM THE AMERICAN ACADEMY OF NEUROLOGY (AAN) 63RD ANNUAL MEETING, HONOLULU, HAWAII, APRIL 9-16, 2011 – Clusterin (apoJ) is a heterodimeric protein that may play a role in amyloid plaque formation by acting as an extracellular chaperone (for a review see Thambisetty M. Biomark 2010; 4: 831-834; free full text at

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page